105 related articles for article (PubMed ID: 21209384)
41. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.
Hiratsuka S; Maru Y; Okada A; Seiki M; Noda T; Shibuya M
Cancer Res; 2001 Feb; 61(3):1207-13. PubMed ID: 11221852
[TBL] [Abstract][Full Text] [Related]
42. VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing.
Santos SC; Miguel C; Domingues I; Calado A; Zhu Z; Wu Y; Dias S
Exp Cell Res; 2007 May; 313(8):1561-74. PubMed ID: 17382929
[TBL] [Abstract][Full Text] [Related]
43. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta.
Li H; Gu B; Zhang Y; Lewis DF; Wang Y
Placenta; 2005; 26(2-3):210-7. PubMed ID: 15708122
[TBL] [Abstract][Full Text] [Related]
44. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation.
Roberts DM; Kearney JB; Johnson JH; Rosenberg MP; Kumar R; Bautch VL
Am J Pathol; 2004 May; 164(5):1531-5. PubMed ID: 15111299
[TBL] [Abstract][Full Text] [Related]
45. Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab.
Karp JE; Gojo I; Pili R; Gocke CD; Greer J; Guo C; Qian D; Morris L; Tidwell M; Chen H; Zwiebel J
Clin Cancer Res; 2004 Jun; 10(11):3577-85. PubMed ID: 15173063
[TBL] [Abstract][Full Text] [Related]
46. Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2.
Hua KT; Lee WJ; Yang SF; Chen CK; Hsiao M; Ku CC; Wei LH; Kuo ML; Chien MH
Biochim Biophys Acta; 2014 Feb; 1843(2):387-97. PubMed ID: 24184161
[TBL] [Abstract][Full Text] [Related]
47. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
48. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
50. The effects of angiogenic growth factors on extravillous trophoblast invasion and motility.
Lash GE; Cartwright JE; Whitley GS; Trew AJ; Baker PN
Placenta; 1999 Nov; 20(8):661-7. PubMed ID: 10527820
[TBL] [Abstract][Full Text] [Related]
51. Role of plasma membrane caveolae/lipid rafts in VEGF-induced redox signaling in human leukemia cells.
Caliceti C; Zambonin L; Rizzo B; Fiorentini D; Vieceli Dalla Sega F; Hrelia S; Prata C
Biomed Res Int; 2014; 2014():857504. PubMed ID: 24738074
[TBL] [Abstract][Full Text] [Related]
52. Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells.
Karajannis MA; Vincent L; Direnzo R; Shmelkov SV; Zhang F; Feldman EJ; Bohlen P; Zhu Z; Sun H; Kussie P; Rafii S
Leukemia; 2006 Jun; 20(6):979-86. PubMed ID: 16598308
[TBL] [Abstract][Full Text] [Related]
53. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.
Shih SC; Ju M; Liu N; Smith LE
J Clin Invest; 2003 Jul; 112(1):50-7. PubMed ID: 12840058
[TBL] [Abstract][Full Text] [Related]
54. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
Viglietto G; Maglione D; Rambaldi M; Cerutti J; Romano A; Trapasso F; Fedele M; Ippolito P; Chiappetta G; Botti G
Oncogene; 1995 Oct; 11(8):1569-79. PubMed ID: 7478581
[TBL] [Abstract][Full Text] [Related]
55. Stimulatory Effect of Vascular Endothelial Growth Factor on Proliferation and Migration of Porcine Trophectoderm Cells and Their Regulation by the Phosphatidylinositol-3-Kinase-AKT and Mitogen-Activated Protein Kinase Cell Signaling Pathways.
Jeong W; Kim J; Bazer FW; Song G
Biol Reprod; 2014 Mar; 90(3):50. PubMed ID: 24451985
[TBL] [Abstract][Full Text] [Related]
56. 111In- or 99mTc-labeled recombinant VEGF bioconjugates: in vitro evaluation of their cytotoxicity on porcine aortic endothelial cells overexpressing Flt-1 receptors.
Chan C; Cai Z; Su R; Reilly RM
Nucl Med Biol; 2010 Feb; 37(2):105-15. PubMed ID: 20152709
[TBL] [Abstract][Full Text] [Related]
57. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4.
Broggini M; Marchini SV; Galliera E; Borsotti P; Taraboletti G; Erba E; Sironi M; Jimeno J; Faircloth GT; Giavazzi R; D'Incalci M
Leukemia; 2003 Jan; 17(1):52-9. PubMed ID: 12529660
[TBL] [Abstract][Full Text] [Related]
58. Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia.
Bellik L; Vinci MC; Filippi S; Ledda F; Parenti A
Br J Pharmacol; 2005 Oct; 146(4):568-75. PubMed ID: 16086034
[TBL] [Abstract][Full Text] [Related]
59. The role of VEGF and a functional link between VEGF and p27Kip1 in acute myeloid leukemia.
Wegiel B; Ekberg J; Talasila KM; Jalili S; Persson JL
Leukemia; 2009 Feb; 23(2):251-61. PubMed ID: 18987662
[TBL] [Abstract][Full Text] [Related]
60. Flt-1 expression influences apoptotic susceptibility of vascular smooth muscle cells through the NF-kappaB/IAP-1 pathway.
Orlandi A; Ferlosio A; Arcuri G; Scioli MG; De Falco S; Spagnoli LG
Cardiovasc Res; 2010 Jan; 85(1):214-23. PubMed ID: 19720604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
